 | • レポートコード：MRC2312MG01914 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品 |
| Single User | ￥468,000 (USD3,250) | ▷ お問い合わせ |
| Multi User | ￥608,400 (USD4,225) | ▷ お問い合わせ |
| Enterprise User | ￥702,000 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Global CD19 Target Drug Market 調査レポートは次の情報を含め、グローバルにおけるのCD19標的薬市場規模と予測を収録しています。 ・世界のCD19標的薬市場：売上、2018年-2023年、2024年-2029年 ・世界のCD19標的薬市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界のCD19標的薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「CD19ターゲット」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。 CD19標的薬のグローバル主要企業は、ADC Therapeutics SA、 Bristol Myers Squibb、 Kite Pharma, Inc.、 Viela Bio、 Novartis Pharma AG、 Amgen, Inc.、 Juventas、 FOSUN PHARMA、 JW Therapeuticsなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 マーケットモニターグローバル社は、CD19標的薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別マーケット分析】 世界のCD19標的薬市場：タイプ別、2018年-2023年、2024年-2029年 世界のCD19標的薬市場：タイプ別市場シェア、2022年 ・CD19ターゲット、CD19+CD3ターゲット、CD19+DNAターゲット 世界のCD19標的薬市場：用途別、2018年-2023年、2024年-2029年 世界のCD19標的薬市場：用途別市場シェア、2022年 ・リンパ腫、急性リンパ性白血病、その他 世界のCD19標的薬市場：地域・国別、2018年-2023年、2024年-2029年 世界のCD19標的薬市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競争分析】 また、当レポートは主要な参入企業の分析を提供します。 ・主要企業におけるCD19標的薬のグローバル売上、2018年-2023年 ・主要企業におけるCD19標的薬のグローバル売上シェア、2022年 ・主要企業におけるCD19標的薬のグローバル販売量、2018年-2023年 ・主要企業におけるCD19標的薬のグローバル販売量シェア、2022年 さらに、当レポートは主要企業の情報を提示します。 ADC Therapeutics SA、 Bristol Myers Squibb、 Kite Pharma, Inc.、 Viela Bio、 Novartis Pharma AG、 Amgen, Inc.、 Juventas、 FOSUN PHARMA、 JW Therapeutics ************************************************************* ・調査・分析レポートの概要 CD19標的薬市場の定義 市場セグメント 世界のCD19標的薬市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界のCD19標的薬市場規模 世界のCD19標的薬市場規模：2022年 VS 2029年 世界のCD19標的薬市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでのCD19標的薬の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業のCD19標的薬製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：CD19ターゲット、CD19+CD3ターゲット、CD19+DNAターゲット CD19標的薬のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：リンパ腫、急性リンパ性白血病、その他 CD19標的薬の用途別グローバル売上・予測 ・地域別市場分析 地域別CD19標的薬市場規模 2022年と2029年 地域別CD19標的薬売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど） ADC Therapeutics SA、 Bristol Myers Squibb、 Kite Pharma, Inc.、 Viela Bio、 Novartis Pharma AG、 Amgen, Inc.、 Juventas、 FOSUN PHARMA、 JW Therapeutics ... |
This research report provides a comprehensive analysis of the CD19 Target Drug market, focusing on the current trends, market dynamics, and future prospects. The report explores the global CD19 Target Drug market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of CD19 Target Drug, challenges faced by the industry, and potential opportunities for market players.
The global CD19 Target Drug market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The CD19 Target Drug market presents opportunities for various stakeholders, including Lymphoma, Acute Lymphoblastic Leukemia. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in CD19 Target Drug market. Additionally, the growing consumer demand present avenues for market expansion.
The global CD19 Target Drug market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period.
Key Features:
The research report on the CD19 Target Drug market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the CD19 Target Drug market.
Market Overview: The report provides a comprehensive overview of the CD19 Target Drug market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., CD19 Target, CD19+CD3 Target), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the CD19 Target Drug market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the CD19 Target Drug market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the CD19 Target Drug market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the CD19 Target Drug market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the CD19 Target Drug market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the CD19 Target Drug market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for CD19 Target Drug, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the CD19 Target Drug market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
CD19 Target Drug market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
CD19 Target
CD19+CD3 Target
CD19+DNA Target
Market segment by Application
Lymphoma
Acute Lymphoblastic Leukemia
Other
Global CD19 Target Drug Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
ADC Therapeutics SA
Bristol Myers Squibb
Kite Pharma, Inc.
Viela Bio
Novartis Pharma AG
Amgen, Inc.
Juventas
FOSUN PHARMA
JW Therapeutics
Outline of Major Chapters:
Chapter 1: Introduces the definition of CD19 Target Drug, market overview.
Chapter 2: Global CD19 Target Drug market size in revenue and volume.
Chapter 3: Detailed analysis of CD19 Target Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of CD19 Target Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global CD19 Target Drug capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 CD19 Target Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global CD19 Target Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global CD19 Target Drug Overall Market Size
2.1 Global CD19 Target Drug Market Size: 2022 VS 2029
2.2 Global CD19 Target Drug Revenue, Prospects & Forecasts: 2018-2029
2.3 Global CD19 Target Drug Sales: 2018-2029
3 Company Landscape
3.1 Top CD19 Target Drug Players in Global Market
3.2 Top Global CD19 Target Drug Companies Ranked by Revenue
3.3 Global CD19 Target Drug Revenue by Companies
3.4 Global CD19 Target Drug Sales by Companies
3.5 Global CD19 Target Drug Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 CD19 Target Drug Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers CD19 Target Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 CD19 Target Drug Players in Global Market
3.8.1 List of Global Tier 1 CD19 Target Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 CD19 Target Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global CD19 Target Drug Market Size Markets, 2022 & 2029
4.1.2 CD19 Target
4.1.3 CD19+CD3 Target
4.1.4 CD19+DNA Target
4.2 By Type – Global CD19 Target Drug Revenue & Forecasts
4.2.1 By Type – Global CD19 Target Drug Revenue, 2018-2023
4.2.2 By Type – Global CD19 Target Drug Revenue, 2024-2029
4.2.3 By Type – Global CD19 Target Drug Revenue Market Share, 2018-2029
4.3 By Type – Global CD19 Target Drug Sales & Forecasts
4.3.1 By Type – Global CD19 Target Drug Sales, 2018-2023
4.3.2 By Type – Global CD19 Target Drug Sales, 2024-2029
4.3.3 By Type – Global CD19 Target Drug Sales Market Share, 2018-2029
4.4 By Type – Global CD19 Target Drug Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global CD19 Target Drug Market Size, 2022 & 2029
5.1.2 Lymphoma
5.1.3 Acute Lymphoblastic Leukemia
5.1.4 Other
5.2 By Application – Global CD19 Target Drug Revenue & Forecasts
5.2.1 By Application – Global CD19 Target Drug Revenue, 2018-2023
5.2.2 By Application – Global CD19 Target Drug Revenue, 2024-2029
5.2.3 By Application – Global CD19 Target Drug Revenue Market Share, 2018-2029
5.3 By Application – Global CD19 Target Drug Sales & Forecasts
5.3.1 By Application – Global CD19 Target Drug Sales, 2018-2023
5.3.2 By Application – Global CD19 Target Drug Sales, 2024-2029
5.3.3 By Application – Global CD19 Target Drug Sales Market Share, 2018-2029
5.4 By Application – Global CD19 Target Drug Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global CD19 Target Drug Market Size, 2022 & 2029
6.2 By Region – Global CD19 Target Drug Revenue & Forecasts
6.2.1 By Region – Global CD19 Target Drug Revenue, 2018-2023
6.2.2 By Region – Global CD19 Target Drug Revenue, 2024-2029
6.2.3 By Region – Global CD19 Target Drug Revenue Market Share, 2018-2029
6.3 By Region – Global CD19 Target Drug Sales & Forecasts
6.3.1 By Region – Global CD19 Target Drug Sales, 2018-2023
6.3.2 By Region – Global CD19 Target Drug Sales, 2024-2029
6.3.3 By Region – Global CD19 Target Drug Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America CD19 Target Drug Revenue, 2018-2029
6.4.2 By Country – North America CD19 Target Drug Sales, 2018-2029
6.4.3 US CD19 Target Drug Market Size, 2018-2029
6.4.4 Canada CD19 Target Drug Market Size, 2018-2029
6.4.5 Mexico CD19 Target Drug Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe CD19 Target Drug Revenue, 2018-2029
6.5.2 By Country – Europe CD19 Target Drug Sales, 2018-2029
6.5.3 Germany CD19 Target Drug Market Size, 2018-2029
6.5.4 France CD19 Target Drug Market Size, 2018-2029
6.5.5 U.K. CD19 Target Drug Market Size, 2018-2029
6.5.6 Italy CD19 Target Drug Market Size, 2018-2029
6.5.7 Russia CD19 Target Drug Market Size, 2018-2029
6.5.8 Nordic Countries CD19 Target Drug Market Size, 2018-2029
6.5.9 Benelux CD19 Target Drug Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia CD19 Target Drug Revenue, 2018-2029
6.6.2 By Region – Asia CD19 Target Drug Sales, 2018-2029
6.6.3 China CD19 Target Drug Market Size, 2018-2029
6.6.4 Japan CD19 Target Drug Market Size, 2018-2029
6.6.5 South Korea CD19 Target Drug Market Size, 2018-2029
6.6.6 Southeast Asia CD19 Target Drug Market Size, 2018-2029
6.6.7 India CD19 Target Drug Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America CD19 Target Drug Revenue, 2018-2029
6.7.2 By Country – South America CD19 Target Drug Sales, 2018-2029
6.7.3 Brazil CD19 Target Drug Market Size, 2018-2029
6.7.4 Argentina CD19 Target Drug Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa CD19 Target Drug Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa CD19 Target Drug Sales, 2018-2029
6.8.3 Turkey CD19 Target Drug Market Size, 2018-2029
6.8.4 Israel CD19 Target Drug Market Size, 2018-2029
6.8.5 Saudi Arabia CD19 Target Drug Market Size, 2018-2029
6.8.6 UAE CD19 Target Drug Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 ADC Therapeutics SA
7.1.1 ADC Therapeutics SA Company Summary
7.1.2 ADC Therapeutics SA Business Overview
7.1.3 ADC Therapeutics SA CD19 Target Drug Major Product Offerings
7.1.4 ADC Therapeutics SA CD19 Target Drug Sales and Revenue in Global (2018-2023)
7.1.5 ADC Therapeutics SA Key News & Latest Developments
7.2 Bristol Myers Squibb
7.2.1 Bristol Myers Squibb Company Summary
7.2.2 Bristol Myers Squibb Business Overview
7.2.3 Bristol Myers Squibb CD19 Target Drug Major Product Offerings
7.2.4 Bristol Myers Squibb CD19 Target Drug Sales and Revenue in Global (2018-2023)
7.2.5 Bristol Myers Squibb Key News & Latest Developments
7.3 Kite Pharma, Inc.
7.3.1 Kite Pharma, Inc. Company Summary
7.3.2 Kite Pharma, Inc. Business Overview
7.3.3 Kite Pharma, Inc. CD19 Target Drug Major Product Offerings
7.3.4 Kite Pharma, Inc. CD19 Target Drug Sales and Revenue in Global (2018-2023)
7.3.5 Kite Pharma, Inc. Key News & Latest Developments
7.4 Viela Bio
7.4.1 Viela Bio Company Summary
7.4.2 Viela Bio Business Overview
7.4.3 Viela Bio CD19 Target Drug Major Product Offerings
7.4.4 Viela Bio CD19 Target Drug Sales and Revenue in Global (2018-2023)
7.4.5 Viela Bio Key News & Latest Developments
7.5 Novartis Pharma AG
7.5.1 Novartis Pharma AG Company Summary
7.5.2 Novartis Pharma AG Business Overview
7.5.3 Novartis Pharma AG CD19 Target Drug Major Product Offerings
7.5.4 Novartis Pharma AG CD19 Target Drug Sales and Revenue in Global (2018-2023)
7.5.5 Novartis Pharma AG Key News & Latest Developments
7.6 Amgen, Inc.
7.6.1 Amgen, Inc. Company Summary
7.6.2 Amgen, Inc. Business Overview
7.6.3 Amgen, Inc. CD19 Target Drug Major Product Offerings
7.6.4 Amgen, Inc. CD19 Target Drug Sales and Revenue in Global (2018-2023)
7.6.5 Amgen, Inc. Key News & Latest Developments
7.7 Juventas
7.7.1 Juventas Company Summary
7.7.2 Juventas Business Overview
7.7.3 Juventas CD19 Target Drug Major Product Offerings
7.7.4 Juventas CD19 Target Drug Sales and Revenue in Global (2018-2023)
7.7.5 Juventas Key News & Latest Developments
7.8 FOSUN PHARMA
7.8.1 FOSUN PHARMA Company Summary
7.8.2 FOSUN PHARMA Business Overview
7.8.3 FOSUN PHARMA CD19 Target Drug Major Product Offerings
7.8.4 FOSUN PHARMA CD19 Target Drug Sales and Revenue in Global (2018-2023)
7.8.5 FOSUN PHARMA Key News & Latest Developments
7.9 JW Therapeutics
7.9.1 JW Therapeutics Company Summary
7.9.2 JW Therapeutics Business Overview
7.9.3 JW Therapeutics CD19 Target Drug Major Product Offerings
7.9.4 JW Therapeutics CD19 Target Drug Sales and Revenue in Global (2018-2023)
7.9.5 JW Therapeutics Key News & Latest Developments
8 Global CD19 Target Drug Production Capacity, Analysis
8.1 Global CD19 Target Drug Production Capacity, 2018-2029
8.2 CD19 Target Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global CD19 Target Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 CD19 Target Drug Supply Chain Analysis
10.1 CD19 Target Drug Industry Value Chain
10.2 CD19 Target Drug Upstream Market
10.3 CD19 Target Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 CD19 Target Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
Table 1. Key Players of CD19 Target Drug in Global Market
Table 2. Top CD19 Target Drug Players in Global Market, Ranking by Revenue (2022)
Table 3. Global CD19 Target Drug Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global CD19 Target Drug Revenue Share by Companies, 2018-2023
Table 5. Global CD19 Target Drug Sales by Companies, (K Units), 2018-2023
Table 6. Global CD19 Target Drug Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers CD19 Target Drug Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers CD19 Target Drug Product Type
Table 9. List of Global Tier 1 CD19 Target Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 CD19 Target Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global CD19 Target Drug Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global CD19 Target Drug Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global CD19 Target Drug Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global CD19 Target Drug Sales (K Units), 2018-2023
Table 15. By Type - Global CD19 Target Drug Sales (K Units), 2024-2029
Table 16. By Application – Global CD19 Target Drug Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global CD19 Target Drug Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global CD19 Target Drug Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global CD19 Target Drug Sales (K Units), 2018-2023
Table 20. By Application - Global CD19 Target Drug Sales (K Units), 2024-2029
Table 21. By Region – Global CD19 Target Drug Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global CD19 Target Drug Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global CD19 Target Drug Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global CD19 Target Drug Sales (K Units), 2018-2023
Table 25. By Region - Global CD19 Target Drug Sales (K Units), 2024-2029
Table 26. By Country - North America CD19 Target Drug Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America CD19 Target Drug Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America CD19 Target Drug Sales, (K Units), 2018-2023
Table 29. By Country - North America CD19 Target Drug Sales, (K Units), 2024-2029
Table 30. By Country - Europe CD19 Target Drug Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe CD19 Target Drug Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe CD19 Target Drug Sales, (K Units), 2018-2023
Table 33. By Country - Europe CD19 Target Drug Sales, (K Units), 2024-2029
Table 34. By Region - Asia CD19 Target Drug Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia CD19 Target Drug Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia CD19 Target Drug Sales, (K Units), 2018-2023
Table 37. By Region - Asia CD19 Target Drug Sales, (K Units), 2024-2029
Table 38. By Country - South America CD19 Target Drug Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America CD19 Target Drug Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America CD19 Target Drug Sales, (K Units), 2018-2023
Table 41. By Country - South America CD19 Target Drug Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa CD19 Target Drug Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa CD19 Target Drug Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa CD19 Target Drug Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa CD19 Target Drug Sales, (K Units), 2024-2029
Table 46. ADC Therapeutics SA Company Summary
Table 47. ADC Therapeutics SA CD19 Target Drug Product Offerings
Table 48. ADC Therapeutics SA CD19 Target Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. ADC Therapeutics SA Key News & Latest Developments
Table 50. Bristol Myers Squibb Company Summary
Table 51. Bristol Myers Squibb CD19 Target Drug Product Offerings
Table 52. Bristol Myers Squibb CD19 Target Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Bristol Myers Squibb Key News & Latest Developments
Table 54. Kite Pharma, Inc. Company Summary
Table 55. Kite Pharma, Inc. CD19 Target Drug Product Offerings
Table 56. Kite Pharma, Inc. CD19 Target Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Kite Pharma, Inc. Key News & Latest Developments
Table 58. Viela Bio Company Summary
Table 59. Viela Bio CD19 Target Drug Product Offerings
Table 60. Viela Bio CD19 Target Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Viela Bio Key News & Latest Developments
Table 62. Novartis Pharma AG Company Summary
Table 63. Novartis Pharma AG CD19 Target Drug Product Offerings
Table 64. Novartis Pharma AG CD19 Target Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Novartis Pharma AG Key News & Latest Developments
Table 66. Amgen, Inc. Company Summary
Table 67. Amgen, Inc. CD19 Target Drug Product Offerings
Table 68. Amgen, Inc. CD19 Target Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Amgen, Inc. Key News & Latest Developments
Table 70. Juventas Company Summary
Table 71. Juventas CD19 Target Drug Product Offerings
Table 72. Juventas CD19 Target Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Juventas Key News & Latest Developments
Table 74. FOSUN PHARMA Company Summary
Table 75. FOSUN PHARMA CD19 Target Drug Product Offerings
Table 76. FOSUN PHARMA CD19 Target Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. FOSUN PHARMA Key News & Latest Developments
Table 78. JW Therapeutics Company Summary
Table 79. JW Therapeutics CD19 Target Drug Product Offerings
Table 80. JW Therapeutics CD19 Target Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. JW Therapeutics Key News & Latest Developments
Table 82. CD19 Target Drug Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 83. Global CD19 Target Drug Capacity Market Share of Key Manufacturers, 2021-2023
Table 84. Global CD19 Target Drug Production by Region, 2018-2023 (K Units)
Table 85. Global CD19 Target Drug Production by Region, 2024-2029 (K Units)
Table 86. CD19 Target Drug Market Opportunities & Trends in Global Market
Table 87. CD19 Target Drug Market Drivers in Global Market
Table 88. CD19 Target Drug Market Restraints in Global Market
Table 89. CD19 Target Drug Raw Materials
Table 90. CD19 Target Drug Raw Materials Suppliers in Global Market
Table 91. Typical CD19 Target Drug Downstream
Table 92. CD19 Target Drug Downstream Clients in Global Market
Table 93. CD19 Target Drug Distributors and Sales Agents in Global Market
List of Figures
Figure 1. CD19 Target Drug Segment by Type in 2022
Figure 2. CD19 Target Drug Segment by Application in 2022
Figure 3. Global CD19 Target Drug Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global CD19 Target Drug Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global CD19 Target Drug Revenue, 2018-2029 (US$, Mn)
Figure 7. CD19 Target Drug Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by CD19 Target Drug Revenue in 2022
Figure 9. By Type - Global CD19 Target Drug Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global CD19 Target Drug Revenue Market Share, 2018-2029
Figure 11. By Type - Global CD19 Target Drug Sales Market Share, 2018-2029
Figure 12. By Type - Global CD19 Target Drug Price (US$/Unit), 2018-2029
Figure 13. By Application - Global CD19 Target Drug Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global CD19 Target Drug Revenue Market Share, 2018-2029
Figure 15. By Application - Global CD19 Target Drug Sales Market Share, 2018-2029
Figure 16. By Application - Global CD19 Target Drug Price (US$/Unit), 2018-2029
Figure 17. By Region - Global CD19 Target Drug Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global CD19 Target Drug Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global CD19 Target Drug Revenue Market Share, 2018-2029
Figure 20. By Region - Global CD19 Target Drug Sales Market Share, 2018-2029
Figure 21. By Country - North America CD19 Target Drug Revenue Market Share, 2018-2029
Figure 22. By Country - North America CD19 Target Drug Sales Market Share, 2018-2029
Figure 23. US CD19 Target Drug Revenue, (US$, Mn), 2018-2029
Figure 24. Canada CD19 Target Drug Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico CD19 Target Drug Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe CD19 Target Drug Revenue Market Share, 2018-2029
Figure 27. By Country - Europe CD19 Target Drug Sales Market Share, 2018-2029
Figure 28. Germany CD19 Target Drug Revenue, (US$, Mn), 2018-2029
Figure 29. France CD19 Target Drug Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. CD19 Target Drug Revenue, (US$, Mn), 2018-2029
Figure 31. Italy CD19 Target Drug Revenue, (US$, Mn), 2018-2029
Figure 32. Russia CD19 Target Drug Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries CD19 Target Drug Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux CD19 Target Drug Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia CD19 Target Drug Revenue Market Share, 2018-2029
Figure 36. By Region - Asia CD19 Target Drug Sales Market Share, 2018-2029
Figure 37. China CD19 Target Drug Revenue, (US$, Mn), 2018-2029
Figure 38. Japan CD19 Target Drug Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea CD19 Target Drug Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia CD19 Target Drug Revenue, (US$, Mn), 2018-2029
Figure 41. India CD19 Target Drug Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America CD19 Target Drug Revenue Market Share, 2018-2029
Figure 43. By Country - South America CD19 Target Drug Sales Market Share, 2018-2029
Figure 44. Brazil CD19 Target Drug Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina CD19 Target Drug Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa CD19 Target Drug Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa CD19 Target Drug Sales Market Share, 2018-2029
Figure 48. Turkey CD19 Target Drug Revenue, (US$, Mn), 2018-2029
Figure 49. Israel CD19 Target Drug Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia CD19 Target Drug Revenue, (US$, Mn), 2018-2029
Figure 51. UAE CD19 Target Drug Revenue, (US$, Mn), 2018-2029
Figure 52. Global CD19 Target Drug Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production CD19 Target Drug by Region, 2022 VS 2029
Figure 54. CD19 Target Drug Industry Value Chain
Figure 55. Marketing Channels
• 日本語訳：世界のCD19標的薬市場予測2023-2029：CD19ターゲット、CD19+CD3ターゲット、CD19+DNAターゲット
• レポートコード：MRC2312MG01914 ▷ お問い合わせ（見積依頼・ご注文・質問）